| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029671 |
| Receipt No. | R000033900 |
| Official scientific title of the study | Phase 1-2 study on preventive effect of compression therapy using newly developed glove for oxaliplatin-induced peripheral neuropathy in colorectal cancer chemotherapy |
| Date of disclosure of the study information | 2017/11/01 |
| Last modified on | 2019/03/04 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Phase 1-2 study on preventive effect of compression therapy using newly developed glove for oxaliplatin-induced peripheral neuropathy in colorectal cancer chemotherapy
|
|
| Title of the study (Brief title) | Study on preventive effect using newly developed glove for oxaliplatin-induced peripheral neuropathy
|
|
| Region |
|
|
| Condition | |||
| Condition | colorectal cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Examination of preventive effect using newly developed glove for oxaliplatin-induced peripheral neuropathy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Safety and effectiveness of new development glove |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | newly developed glove | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients planning treatment with oxaliplatin
2) Patients who are over 20 years of age at consent acquisition 3) No gender 4) After receiving sufficient explanation for the participation of this study, patients who gained written consent by the patient's free will with sufficient understanding |
|||
| Key exclusion criteria | 1) Patients with no peripheral neuropathy of Grade 1 or higher before starting the study
2) Patients who have not had a history of treatment with L-OHP in the past 3) Patients with disabilities or lesions difficult to wear gloves on the skin 4) Other Research Responsibilities (Sharing) Patients judged by doctors as inappropriate as subjects |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Akiyoshi Kanazawa |
| Organization | Shimane Prefectural Central Hospital |
| Division name | Department of Surgery |
| Address | Himebara 4-1-1. Izumo, Shimane |
| TEL | 0853-22-5111 |
| kana@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Akiyoshi Kanazawa |
| Organization | Shimane Prefectural Central Hospital |
| Division name | Department of Surgery |
| Address | Himebara 4-1-1. Izumo, Shimane |
| TEL | 0853-30-6590 |
| Homepage URL | |
| kana@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Shimane Prefectural Central Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shimane Prefectural Central Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033900 |